Literature DB >> 12053043

Cerebrospinal fluid shunt survival and etiology of failures: a seven-year institutional experience.

Matthew J McGirt1, Jean-Christophe Leveque, John C Wellons, Alan T Villavicencio, John S Hopkins, Herbert E Fuchs, Timoth M George.   

Abstract

BACKGROUND: Innovations in shunt technology and neuroendoscopy have been increasingly applied to shunt management. However, the relative life span of shunts and the etiology of shunt failure have not been characterized recently.
METHODS: We reviewed the records of all shunting procedures at our institution between January 1992 and December 1998. Independent predictors of shunt failure were analyzed via multivariate Cox regression analysis in 836 shunting procedures. Independent predictors of the etiology of failure (infection, proximal obstruction, distal malfunction) were analyzed via multivariate logistic regression analysis in the 383 shunts which failed.
RESULTS: A total of 353 pediatric patients underwent 308 shunt placements and 528 revisions. The risk (hazard ratio; HR) of shunt failure decreased as a function of time in both primary placements and revised shunts. In failed shunts, the odds of infection decreased 4-fold per year of shunt function, while the odds of distal malfunction increased 1.45-fold per year. Increasing number of shunt revisions (HR 1.31, p < 0.05), decreasing patient age in years (HR 1.04, p < 0.001), gestational age <40 weeks (HR 2.15, p < 0.001) but not the etiology of hydrocephalus were associated with an increased risk of shunt failure. Revisions versus primary placements, Dandy-Walker cysts and gestational age <40 weeks were independently associated with proximal, distal and infectious causes of failure, respectively.
CONCLUSIONS: The long-term shunt revision rates observed here are similar to those reported over the past 2 decades. Shunt life span remains poorer in shunt revisions and in younger patients. Patient characteristics may suggest a specific risk and mechanism of failure, aiding in the long-term management of shunted hydrocephalus. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12053043     DOI: 10.1159/000058428

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  50 in total

1.  Selective use of intra-catheter endoscopic-assisted ventricular catheter placement: indications and outcome.

Authors:  Jonathan Roth; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2012-06-24       Impact factor: 1.475

Review 2.  Ventricular shunt infections: immunopathogenesis and clinical management.

Authors:  Yenis Gutierrez-Murgas; Jessica N Snowden
Journal:  J Neuroimmunol       Date:  2014-08-13       Impact factor: 3.478

3.  Time trends and age-related etiologies of pediatric hydrocephalus: results of a groupwise analysis in a clinical cohort.

Authors:  Qura-Tul-Ain Rashid; Muhammad Sohail Salat; Kishwar Enam; Syed Faraz Kazim; Saniya Siraj Godil; Syed Ather Enam; Saleem Perwaiz Iqbal; Syed Iqbal Azam
Journal:  Childs Nerv Syst       Date:  2011-08-05       Impact factor: 1.475

Review 4.  Who will care for me next? Transitioning to adulthood with hydrocephalus.

Authors:  Tamara D Simon; Sara Lamb; Nancy A Murphy; Bonnie Hom; Marion L Walker; Edward B Clark
Journal:  Pediatrics       Date:  2009-10-19       Impact factor: 7.124

5.  A multicenter retrospective comparison of conversion from temporary to permanent cerebrospinal fluid diversion in very low birth weight infants with posthemorrhagic hydrocephalus.

Authors:  John C Wellons; Chevis N Shannon; Abhaya V Kulkarni; Tamara D Simon; Jay Riva-Cambrin; William E Whitehead; W Jerry Oakes; James M Drake; Thomas G Luerssen; Marion L Walker; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2009-07       Impact factor: 2.375

Review 6.  Cerebrospinal Fluid Shunting Complications in Children.

Authors:  Brian W Hanak; Robert H Bonow; Carolyn A Harris; Samuel R Browd
Journal:  Pediatr Neurosurg       Date:  2017-03-02       Impact factor: 1.162

7.  The efficacy of silver-embedded polypropylene-grafted polyethylene glycol-coated ventricular catheters on prevention of shunt catheter infection in rats.

Authors:  Derya Burcu Hazer; Melike Mut; Nazmiye Dinçer; Zeynep Saribas; Baki Hazer; Tunçalp Ozgen
Journal:  Childs Nerv Syst       Date:  2012-02-29       Impact factor: 1.475

Review 8.  Fetal ventriculomegaly: Diagnosis, treatment, and future directions.

Authors:  Jared M Pisapia; Saurabh Sinha; Deborah M Zarnow; Mark P Johnson; Gregory G Heuer
Journal:  Childs Nerv Syst       Date:  2017-05-16       Impact factor: 1.475

9.  Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2018-02-02       Impact factor: 2.375

10.  Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy Gove; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatr       Date:  2016-09-28       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.